Comtech Telecommunications Corp. — FY2026 Form 10-K
Reporting period: Fiscal year ended July 31, 2026. The filing was signed October 14, 2026. Because the planned sale of most of Satellite and Space Communications (S&S) is a material strategic shift, the S&S Disposal Group is presented as discontinued operations and prior periods have been recast. Unless stated otherwise, operating results below are for continuing operations, primarily the Allerium public-safety business.
Business context and strategic transaction
- Allerium provides NG9-1-1 infrastructure, emergency call handling, location, messaging and public-alerting solutions, plus cybersecurity training. Management cites long-term demand from emergency-communications modernization and mobile-network evolution.
- On June 14, 2026, Comtech agreed to sell most of S&S to a Gilat affiliate for a base price of $157.5 million in cash, subject to customary adjustments. Comtech received a $10.0 million advance payment. Closing is expected in calendar 2026, subject to regulatory approvals and other conditions; shareholder approval is not required.
- After closing, Comtech expects to focus on Allerium, use net sale proceeds to substantially reduce debt, and then pursue a broader recapitalization. The company expects to adopt the Allerium name and a new Nasdaq symbol in fiscal 2027.
- Management reports that its transformation plan has contributed to six consecutive quarters of positive consolidated operating cash flow and removal of substantial doubt about the company’s ability to continue as a going concern in November 2025.
Financial performance and liquidity
| Metric | FY2026 | FY2025 |
|---|---|---|
| Continuing-operations net sales | $249.6 million | $300.9 million |
| Gross profit / gross margin | $97.2 million / 38.9% | $95.2 million / 31.6% |
| Operating loss, continuing operations | $18.2 million | $29.9 million |
| Net loss, continuing operations | $18.3 million | $19.0 million |
| Net loss, discontinued operations | $17.9 million | $136.3 million |
| Net loss attributable to common stockholders | $68.9 million | $204.3 million |
| Adjusted EBITDA, continuing operations (non-GAAP) | $20.6 million (8.3% of sales) | $16.4 million (5.5% of sales) |
| Operating cash flow, continuing operations | $25.0 million | $(29.2) million |
| Consolidated operating cash flow, including discontinued operations | $37.4 million | $(8.3) million |
- Sales declined 17.0% year over year. Management says that, excluding the largely wound-down, low-margin legacy VSAT and GFSR contracts, continuing-operations sales were comparable to FY2025. Those contracts contributed $0.3 million of FY2026 sales versus $48.5 million in FY2025.
- Gross margin improved, which management attributes to customer adoption and migration of public-safety answering points onto NG9-1-1 and call-handling platforms, including a shift toward recurring maintenance revenue.
- GAAP net loss attributable to common stockholders includes $32.8 million of net preferred-stock dividends. FY2026 also included a $22.1 million non-cash benefit from remeasurement of warrants and derivatives. Adjusted EBITDA is a non-GAAP measure; the filing cautions it is not a substitute for GAAP results.
- Cash and cash equivalents were $35.0 million at year-end. Available consolidated liquidity was $61.3 million, including $34.0 million of qualified cash and $27.3 million available under the revolver. At October 13, 2026, stated liquidity had decreased to $51.3 million, including $24.0 million of qualified cash.
- At July 31, 2026, borrowings were $108.5 million under the senior Credit Facility and $102.0 million under the Subordinated Credit Facility, before a $32.5 million make-whole amount on a portion of subordinated debt. Preferred-stock liquidation preference was $223.2 million. The company reported a total effective interest rate of approximately 19.7% for FY2026 and a current cash borrowing rate under the Credit Facility of approximately 14.4%.
- Capital expenditures and other investing activity resulted in $14.7 million of continuing-operations cash use. Continuing-operations cash flow benefited from working-capital improvements and timing of contract performance, billings and collections; management reported $77.9 million of contract assets, including discontinued operations, at year-end.
Material changes versus the prior period
- FY2025’s discontinued-operations loss included $74.3 million of impairment charges; FY2026 discontinued-operations loss was substantially lower. The planned S&S sale also changes the company’s continuing business profile and reduces diversification.
- Continuing-operations gross margin rose 7.3 percentage points, while gross profit increased $2.0 million despite lower reported sales. Adjusted EBITDA increased $4.2 million.
- Continuing-operations operating cash flow improved by $54.2 million, from a $29.2 million use to $25.0 million provided. Management attributes the improvement mainly to working-capital management and contract timing.
- Debt amendments extended the covenant holiday through July 31, 2027, waived the FY2026 excess-cash-flow prepayment, deferred certain make-whole adjustments, and extended preferred-stock redemption and cash-dividend rights. Covenant testing is scheduled to resume in FY2027.
Outlook, risks and unusual items
- Outlook: The filing provides no specific FY2027 revenue, earnings or cash-flow guidance. Management expects available liquidity and anticipated operating cash flows to fund needs over the next year, but says this depends on execution, positive cash generation, revolver availability and potentially outside capital.
- Backlog: Funded backlog was $520.4 million at July 31, 2026, versus $506.3 million a year earlier. Management estimates approximately 80% will convert to sales within 36 months and approximately 40% during FY2027. These are estimates; contracts may be modified or cancelled, and government and local-government funding can be uncertain. Revenue visibility, including certain unfunded multi-year contract value, was $862.0 million.
- Customer concentration: A domestic top-tier mobile-network operator represented 17.0% of FY2026 net sales and a Northeastern state represented 12.6%. The company’s largest customer secured a multi-year contract extension valued at more than $130 million.
- Transaction and financing risk: The S&S sale remains subject to regulatory approvals and closing conditions. Failure or delay could affect operations, liquidity, market confidence and expected debt reduction. The company expects 65% of net sale proceeds to prepay senior debt and 35% to prepay subordinated debt, subject to facility terms.
- Other key risks: High debt costs and preferred-stock obligations; covenant compliance when testing resumes; contract execution and collection of unbilled receivables; customer concentration; supply-chain constraints and tariffs; government funding delays and shutdowns; cybersecurity threats; and technology, competition and regulatory changes.
- Controls: Management concluded disclosure controls and internal control over financial reporting were ineffective at year-end because of material weaknesses in the control environment and revenue-recognition and contract-liability controls. Deloitte issued an adverse opinion on internal control, while expressing an unqualified opinion on the financial statements. Some previously identified weaknesses were remediated, but the remaining weaknesses require further testing.
- Unusual items and contingencies: FY2026 included $10.0 million of restructuring costs and $1.2 million of CEO transition costs. A former CEO’s claims were withdrawn from arbitration, but Comtech’s counterclaims remain pending; a separate advancement-of-legal-expenses action was filed in Delaware in August 2026. The company’s voluntary export-compliance matter was closed by the State Department in September 2026 without further action or civil penalty.
Most important facts for investors to verify
- Whether the Gilat transaction receives all required approvals and closes on the expected terms and timing, and the final net proceeds after adjustments, escrow and transaction costs.
- The actual amount and timing of debt repayment and the resulting debt service, preferred-stock obligations, liquidity and capital structure after closing.
- Whether Allerium sustains positive operating cash flow and converts backlog into revenue and collections, particularly given contract funding, customer concentration and contract-asset balances.
- Progress in remediating the remaining material weaknesses, especially revenue recognition and contract liabilities, and whether controls operate effectively over a sufficient testing period.
- Whether margin and recurring-revenue improvements persist while the company absorbs restructuring, transition costs and the loss of the S&S business.